What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
Alan J. Thomas mainly investigates Dementia, Psychiatry, Depression, Internal medicine and Late life depression.
His work on Alzheimer's disease expands to the thematically related Dementia.
Alan J. Thomas combines subjects such as Rivastigmine and Risk factor with his study of Psychiatry.
His research in Depression intersects with topics in Neurocognitive, Entorhinal cortex and Clinical psychology.
His Internal medicine study combines topics from a wide range of disciplines, such as Placebo and Endocrinology.
His work deals with themes such as Hippocampus, Prefrontal cortex and Audiology, which intersect with Late life depression.
His most cited work include:
- Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial (321 citations)
- Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. (315 citations)
- Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis (253 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Dementia, Dementia with Lewy bodies, Disease, Neuroscience and Psychiatry.
His research integrates issues of Alzheimer's disease, Cognition and Gerontology in his study of Dementia.
His Dementia with Lewy bodies study deals with Audiology intersecting with Electroencephalography.
Alan J. Thomas interconnects Clinical trial, Bioinformatics, Pediatrics and Physical medicine and rehabilitation in the investigation of issues within Disease.
His Neuroscience study frequently draws connections to adjacent fields such as White matter.
His Psychiatry research includes elements of Placebo, Older people and Parkinson's disease.
He most often published in these fields:
- Dementia (51.86%)
- Dementia with Lewy bodies (39.66%)
- Disease (28.81%)
What were the highlights of his more recent work (between 2018-2021)?
- Dementia (51.86%)
- Dementia with Lewy bodies (39.66%)
- Disease (28.81%)
In recent papers he was focusing on the following fields of study:
Alan J. Thomas mostly deals with Dementia, Dementia with Lewy bodies, Disease, Neuroscience and Cognition.
His Dementia research integrates issues from Physical medicine and rehabilitation, Pediatrics and Neuropsychology.
His research on Dementia with Lewy bodies concerns the broader Internal medicine.
His work in the fields of Disease, such as Neuropathology, overlaps with other areas such as Repeated measures design.
His research in the fields of Cholinergic, Dynamic functional connectivity, Resting state fMRI and Neuroimaging overlaps with other disciplines such as Nucleus basalis.
His study looks at the relationship between Cognition and topics such as Electroencephalography, which overlap with Biomarker.
Between 2018 and 2021, his most popular works were:
- Dementia with Lewy bodies: an update and outlook (62 citations)
- Research criteria for the diagnosis of prodromal dementia with Lewy bodies (61 citations)
- New evidence on the management of Lewy body dementia. (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
His primary scientific interests are in Dementia with Lewy bodies, Dementia, Disease, Neuroscience and Cognition.
His study in Dementia with Lewy bodies is interdisciplinary in nature, drawing from both Lewy body, Neurology, Cohort and Receiver operating characteristic.
Alan J. Thomas is involved in the study of Dementia that focuses on Cognitive decline in particular.
His Disease study combines topics in areas such as Epigenetics, Computational biology, Cortex and Intensive care medicine.
The concepts of his Neuroscience study are interwoven with issues in Magnetic resonance imaging and Atrophy.
His work in Cognition addresses issues such as Clinical trial, which are connected to fields such as Psychiatry and Clinical significance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
